O. Michael Colvin

9.5k total citations · 1 hit paper
124 papers, 7.0k citations indexed

About

O. Michael Colvin is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, O. Michael Colvin has authored 124 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 45 papers in Oncology and 27 papers in Hematology. Recurrent topics in O. Michael Colvin's work include Hematopoietic Stem Cell Transplantation (24 papers), Cancer therapeutics and mechanisms (16 papers) and Glioma Diagnosis and Treatment (15 papers). O. Michael Colvin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Cancer therapeutics and mechanisms (16 papers) and Glioma Diagnosis and Treatment (15 papers). O. Michael Colvin collaborates with scholars based in United States, Canada and South Korea. O. Michael Colvin's co-authors include Michael P. Gamcsik, Mohit S. Kasibhatla, Stephanie D. Teeter, Adrian Hilton, Henry Brem, George W. Santos, Susan M. Ludeman, Henry S. Friedman, William P. Petros and Rein Saral and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

O. Michael Colvin

124 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glutathione levels in human tumors

2012 505 citations Michael P. Gamcsik, O. Michael Colvin et al. profile →

Peers

Countries citing papers authored by O. Michael Colvin

Since Specialization

Citations

This map shows the geographic impact of O. Michael Colvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Michael Colvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Michael Colvin more than expected).

Fields of papers citing papers by O. Michael Colvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Michael Colvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Michael Colvin. The network helps show where O. Michael Colvin may publish in the future.

Co-authorship network of co-authors of O. Michael Colvin

This figure shows the co-authorship network connecting the top 25 collaborators of O. Michael Colvin. A scholar is included among the top collaborators of O. Michael Colvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Michael Colvin. O. Michael Colvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New approach to the activation of anti-cancer pro-drugs by metalloporphyrin-based cytochrome P450 mimics in all-aqueous biologically relevant system 2006 ·Journal of Inorganic Biochemistry ·Ivan Spasojević, O. Michael Colvin, (unknown), Ines Batinić‐Haberle	30
2	Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners 2006 ·Cancer ·Lisa C. Campbell, Francis J. Keefe, Cindy D. Scipio, Daphne C. McKee, Christopher L. Edwards, Steven H. Herman, Laurie Johnson, O. Michael Colvin, Colleen M. McBride, Craig F. Donatucci	140
3	Cyclophosphamide, but not melphalan or carboplatin, synergistically enhanced topotecan activity against Ewing’s family tumor cell lines in hypoxia 2005 ·Cancer Research ·(unknown), Nino Keshelava, Barry J. Maurer, (unknown), Susan M. Ludeman, O. Michael Colvin, C. Patrick Reynolds	1
4	In vitro induction of fetal hemoglobin in human erythroid progenitor cells 2003 ·Experimental Hematology ·(unknown), (unknown), (unknown), O. Michael Colvin, Russell E. Ware	17
5	Adventures with an Enigmatic Anticancer Drug 2003 ·Cancer Biology & Therapy ·O. Michael Colvin	8
6	Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes 2001 ·Leukemia ·(unknown), (unknown), JB Weinberg, (unknown), (unknown), Joseph O. Moore, O. Michael Colvin, R Silber	16
7	Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamide 2000 ·Cancer Chemotherapy and Pharmacology ·James L. Flowers, Susan M. Ludeman, Michael P. Gamcsik, O. Michael Colvin, (unknown), (unknown), James B. Springer, David J. Adams	35
8	Pre-clinical evaluation of SN-38 and novel camptothecin analogs against human chronic B-cell lymphocytic leukemia lymphocytes 1999 ·Leukemia Research ·Darrel P. Cohen, David J. Adams, James L. Flowers, Monroe E. Wall, Mansukh C. Wani, Govindarajan Manikumar, O. Michael Colvin, Robert Silber	11
9	Predicted and actual BCNU concentrations in normal rabbit brain during intraarterial and intravenous infusions 1996 ·Journal of Neuro-Oncology ·(unknown), (unknown), O. Michael Colvin	10
10	Oxime Derivatives of the Intermediary Oncostatic Metabolites of Cyclophosphamide and Ifosfamide: Synthesis and Deuterium Labeling for Applications to Metabolite Quantification 1995 ·Journal of Pharmaceutical Sciences ·Susan M. Ludeman, (unknown), Kenneth Wong, (unknown), Lawrence W. Anderson, John M. Strong, O. Michael Colvin	17
11	Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model 1995 ·International Journal of Cancer ·Jon Weingart, Reid C. Thompson, Betty Tyler, O. Michael Colvin, Henry Brem	57
12	Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole blood 1995 ·Journal of Chromatography B Biomedical Sciences and Applications ·Lawrence W. Anderson, S. M. LUDEMAN, O. Michael Colvin, L B Grochow, John M. Strong	36
13	Protonation of phosphoramide mustard and other phosphoramides 1993 ·Journal of Medicinal Chemistry ·Michael P. Gamcsik, Susan M. Ludeman, (unknown), Ian J. McLennan, Michael E. Colvin, O. Michael Colvin	20
14	Autologous bone marrow transplant in acute myeloid leukemia in first remission. 1993 ·Journal of Clinical Oncology ·Peter A. Cassileth, Janet Andersen, Hillard M. Lazarus, O. Michael Colvin, J M Bennett, E. Stadtmauer, Herbert Kaizer, Roy S. Weiner, M Edelstein, Martin M. Oken	79
15	Effect of 4‐(Diethylamino)benzaldehyde on Ethanol Metabolism in Mice 1993 ·Alcoholism Clinical and Experimental Research ·(unknown), James J. Potter, O. Michael Colvin, John Hilton, Esteban Mezey	28
16	Thalidomide for the Treatment of Chronic Graft-versus-Host Disease 1992 ·New England Journal of Medicine ·Georgia B. Vogelsang, Evan R. Farmer, Allan D. Hess, (unknown), William E. Beschorner, Douglas A. Jabs, Russell L. Corio, L. Levin, O. Michael Colvin, John R. Wingard, George W. Santos	315
17	Autologous bone marrow transplantation with 4‐hydroperoxycyclophosphamide‐purged marrow for acute lymphoblastic leukemia 1991 ·Medical and Pediatric Oncology ·(unknown), Donna Przepiorka, Richard K. Shadduck, Dennis Borochovitz, Elana J. Bloom, O. Michael Colvin, (unknown), Craig S. Rosenfeld	9
18	Structure and expression of the cytosolic aldehyde dehydrogenase gene in cyclophosphamide-resistant murine leukemia L1210 cells 1991 ·Biochemical Pharmacology ·Arthur I. Radin, (unknown), (unknown), O. Michael Colvin, Adrian Hilton	15
19	Forbeck Forum On Improved Drug Delivery to Brain Tumors 1990 ·PubMed ·(unknown), J. Fenstermacher, William Shapiro, J T Kemshead, Mark Chasin, O. Michael Colvin, Mirko Dikšić, (unknown), Andrew Hertler, V. A. Levin, (unknown), (unknown), (unknown), (unknown)	3
20	In Vitro Chemosensitivity of Two Ewing's Sarcoma Cell Lines: Implication for Autologous Bone Marrow Transplantation 1989 ·Cancer Investigation ·(unknown), Subhash C. Gulati, (unknown), Jens Atzpodien, Timothy J. Triche, O. Michael Colvin, Bayard D. Clarkson, (unknown), Brian H. Kushner, Nai‐Kong V. Cheung, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact